it be not entirely dependent on our astrazeneca programme and indeed as have already point out the piece of work in which it be intend to invest hope will get the science right be change the way in which it would create the nasal flu vaccine for child from an egg base to cell base system it have now decide not to do that but to stick to the egg base system think that if the chief scientific adviser or the chief medical officer have anything on which to update the house he she will do so